Table 1.
Clinicopathological features and treatment modalities in groups 1 and 2
| Variable | Group 2 (age≤70 years ) n (%) Group 1 (age >70 years) n (%) | P p |
|---|---|---|
|
Gender |
|
0.26 |
| Male |
504 (70.5) |
|
| |
102 (67.5) |
|
| Female |
211 (29.5) |
|
| |
49 (32.5 |
|
|
ECCOG |
|
0.14 |
| 0 |
41 (27) |
|
| |
210 (29) |
|
| 1 |
80 (53) |
|
| 2 |
405 (56) |
|
| |
30 (20) |
|
| |
100 (15) |
|
|
Histology |
|
0.65 |
| Diffuse adenocarcinoma |
229 (32) |
|
| |
36 (24) |
|
| Intestinal adenocarcinoma |
437 (61) |
|
| |
99 (66) |
|
| Mixed adenocarcinoma |
49 (7) |
|
| |
16 (10) |
|
|
Stomach localization |
|
0.2 |
| Proximal (cardia) |
127 (17.8) |
|
| |
31 (19.6) |
|
| Distal part |
588 (82.2) |
|
| |
120 (79.5) |
|
|
Presentation type |
|
0.4 |
| Metastatic |
345 (51.6) |
|
| |
68 (52.3) |
|
| Non-metastatic |
324 (48.4) |
|
| |
62 (47.7) |
|
|
Perineural invasion |
|
0.5 |
| Present |
210 (73) |
|
| Absent |
40 (74) |
|
| |
77 (27) |
|
| |
14 (26) |
|
|
Lymphovascular invasion |
|
0.21 |
| Present |
230 (80.5) |
|
| Absent |
56 (19.5) |
|
| |
48 (80) |
|
| |
12 (20) |
|
|
Surgical procedure |
|
0.5 |
| Subtotal gastrectomy |
184 (56.8) |
|
| |
30 (48.4) |
|
| Total gastrectomy |
133 (41) |
|
| |
30 (48.4) |
|
| Palliative surgery |
7 (2.2) |
|
| |
2 (3.2) |
|
|
Adjuvant treatment |
|
0.02 |
| Present |
244 (75) |
|
| |
37 (60) |
|
| Absent |
65 (20) |
|
| |
19 (30) |
|
| Unknown |
15 (5) |
|
| |
6 (10) |
|
|
Palliative Treatment |
|
0.007 |
| Chemotherapy |
287 (83.2) |
|
| |
46 (67.6) |
|
| Palliative care |
45 (13) |
|
| |
15 (22.1) |
|
| Unknown |
13 (3.8) |
|
| 7 (10.3) |